Brind.

NICE recommended ALK-Abelló's allergy tablets, which are now available through the National Health Service.

1 report, 1 independent Updated Aug 14

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

National Institute for Health and Care Excellence ALK-Abelló National Health Service

Keep exploring

The entities involved

National Institute for Health and Care Excellence
non-departmental public body of the Department of Health in the United Kingdom
- NICE encourages NHS Trusts in England to report risks due to the ongoing staffing crisis and patient safety issues.Fri 02:07
- A study using data from the Our Future Health programme and guidelines applied in England's primary care.Thu 07:12
ALK-Abelló
Danish pharmaceutical company

Nothing else this week.
National Health Service
publicly-funded healthcare systems in the United Kingdom
- Leading commission into adult social care in England discusses NHS withdrawal and National Care Service proposals.Sun 15:39

Coverage

Newest first; wire copies grouped

Aug 14manilatimes.net